Gujarat Themis Biosyn

244.45
-7.05
(-2.80%)
Market Cap
2,663.68 Cr
EPS
40.72
PE Ratio
52.07
Dividend Yield
0.26 %
Industry
Healthcare
52 Week High
390.00
52 Week low
192.35
PB Ratio
12.27
Debt to Equity
0.01
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
12.39 %
Net Income Growth
2.07 %
Cash Flow Change
62.64 %
ROE
-24.41 %
ROCE
-24.47 %
EBITDA Margin (Avg.)
-7.82 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
32
33
36
39
43
87
94
119
155
174
157
Expenses
25
27
30
33
34
53
50
57
75
91
81
EBITDA
6
6
6
6
10
34
44
62
80
83
76
Operating Profit %
20 %
19 %
17 %
16 %
18 %
37 %
45 %
51 %
50 %
46 %
47 %
Depreciation
1
1
1
1
1
1
2
2
3
4
5
Interest
0
0
0
0
0
1
1
1
0
0
0
Profit Before Tax
5
5
5
5
8
31
41
59
78
79
71
Tax
0
0
1
1
2
8
11
15
20
20
18
Net Profit
5
5
4
4
6
24
30
44
58
59
53
EPS in ₹
3.16
3.19
3.01
2.66
4.41
16.30
20.77
30.03
39.90
40.72
6.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
15
15
21
21
33
64
88
123
166
221
Fixed Assets
10
9
11
11
15
17
19
19
33
38
Current Assets
4
3
8
8
8
29
63
78
62
48
Capital Work in Progress
0
0
0
0
1
0
2
13
21
91
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
5
5
11
10
17
47
67
90
113
92
Total Liabilities
15
15
21
21
33
64
88
123
166
221
Current Liabilities
10
9
12
8
13
17
16
17
15
16
Non Current Liabilities
6
2
1
1
1
5
3
2
2
4
Total Equity
-1
4
8
12
19
42
70
103
149
201
Reserve & Surplus
-8
-3
1
5
11
35
63
96
142
194
Share Capital
7
7
7
7
7
7
7
7
7
7

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
0
0
1
0
-0
3
-4
6
0
Investing Activities
-0
-1
-3
-1
-6
-3
-2
-30
-20
-55
Operating Activities
3
4
3
6
1
1
11
40
40
64
Financing Activities
-3
-3
-0
-4
5
2
-5
-14
-13
-9

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
74.99 %
70.86 %
70.86 %
70.86 %
70.86 %
70.86 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
1.05 %
1.44 %
1.49 %
1.42 %
DIIs
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.02 %
0.03 %
0.03 %
0.02 %
0.82 %
1.18 %
1.17 %
1.17 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
22.07 %
21.61 %
21.89 %
21.64 %
21.30 %
21.41 %
21.60 %
21.85 %
22.09 %
22.13 %
21.85 %
23.40 %
22.26 %
21.17 %
20.44 %
20.12 %
Others
2.90 %
3.36 %
3.08 %
3.34 %
3.67 %
3.56 %
3.38 %
3.12 %
2.90 %
2.84 %
3.11 %
5.71 %
5.00 %
5.35 %
6.03 %
6.42 %
No of Share Holders
10,175
10,158
12,930
13,059
13,917
13,830
14,904
16,550
16,804
17,373
19,846
28,655
29,576
30,280
31,271
30,934

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Technical Indicators